New research suggests that salivary molecules hold potential as realistic diagnostic biomarkers in a bid to tackle Alzheimer’s disease.The study carried out by investigators at the Beaumont Research Institute and published in the Journal of Alzheimer’s Disease, reveals that spit could potentially provide clues to the future of brain health. Currently, Alzheimer’s has no cure, […]Read more "Spit Could Provide Clues to Brain Health"
Dr. Colby’s vision can be summarized in three words – PREDICT, PREVENT, PREVAIL. If science can predict the diseases for which you and your loved ones are at increased risk, we can take action to try to prevent them even before they arise. And if we can prevent disease, we prevail. Genetic technology now makes […]Read more "Outsmart your genes"
Whole genome sequencing (WGS), which is the process of determining an organism’s complete DNA sequence, can be used to identify DNA anomalies that cause disease. Identifying disease-causing DNA abnormalities allows clinicians to better predict an effective course of treatment for the patient. Now, in a series of recent studies, scientists at the University of Missouri […]Read more "Rare feline genetic disorders identified through whole genome sequencing at MU"
23andMe, a genetic testing startup that captured the national imagination a decade ago, appears to have fully emerged from the wilderness. The Food and Drug Administration has cleared the startup to market $199 genetic tests that will tell consumers not whether they have a condition like Parkinson’s or Alzheimer’s, but how likely they might be to […]Read more "23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk"
We’ve entered a new phase in the history of whole genome sequencing (WGS). Consider that researchers at University of Toronto just launched a massive project to sequence the whole genomes of 10,000 people per year. This is truly astounding when you recall that it took 13 years and $3 billion to sequence the first human […]Read more "The genomics intelligence revolution"
It was when my future wife came to visit me in America for the first time that I learned she detested whiskey, or more specifically Scotch whisky, the most popular spiritous liquor of her native Portugal. After some questioning, I suggested she try some Kentucky bourbon. Liking it, she declared, “But this isn’t whisky!” Some […]Read more "Do you Like Whiskey? Maybe It’s Your Genes"
There was no shortage of excitement (some might call it hype) about genomics and personalised healthcare in 2016, but for the vast majority of patients, the benefits of genomics remained tantalizingly out of reach. I have been wondering whether there are reasons to be more optimistic for 2017? Could this be the year that ‘patient […]Read more "Will 2017 be the year when genomic medicine becomes business as usual?"